3Thaveeratitham P,Khovidhunkit W,Patumraj S. High density lipopro- teins(HDL)inhibit endotoxiu induced leukocyte adhesion on endothelial cells in rats:effect of the acute-phaseHDL[J].Clin Hemorheol Microcirc, 2007,36( 1 ) : 8-9.
4Buono C,PangH,Uchida Y,Libby P,Sharpe A,Lichtman AH. B7 1PB7 eostimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low- density lipoprotein receptor- deficient mice[J]. Circulation, 2004,109 ( 16 ) : 2009-2011.
6Suzuki M,Pritchard DK, Becker L,et al.High-density lipoprotein sup- presses the type/ interferon response,a family of potent antiviral im- munoregulators,in macrophages challengedwith lipopolysaccharide [J]. Circulation,2010,122(19) : 1919 -1927.
7Gharavi NM, Gargalovic PS, Chang I, Araujo JA, Clark M J, Szeto WL, et al.High-density lipopmtein modulates oxidized phospho]ipid signaling in human endothelial cells from pminflammatory to antinflarnmatory [J].Ar- terioseler Thromb Vase Biol,2007,27(6),, 1346-1353.
8Smith JD.Dysfunctional HDL as a diagnostic and therapeutic target[J]. Arterioscler Thmmb Vase Biol,2010,30(2)151-155.
9Park SH, Park JH, Kang JS, Kang YH.Involvement of transer ipti0n fac- tors in plasma HDL protection against TNF-alpha-indueed vascular cell adhesion molecule- 1 expression[J].Int J Bioehem Cell Bid, 2003,35 (2) : 168-182.
10Voight BF, Peloso GM, Orho-Melander M, et al.Plasma HDL choles- terol and risk of myocardial infarction: a mendelian randomlsation study [J].Lancet, 2012,380(9841 ) : 572-580.
二级参考文献66
1Bisoendial RJ,Hovingh GK,Levels JH,Lerch PG,Andresen I,Hayden MR,et al.Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high density lipoprotein.Circulation,2003,107 (23):2 944-948
2Li X,Chyu KY,Neto JR,Yano J,Nathwani N,Ferreira C,et al.Differential effects of apolipoprotein A-I-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null mice.Circulation,2004,110 (12):1 701-705
3Navab M,Anantharamaiah GM,Hama S.Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol.Circulation,2002,105 (3):290-292
4Brousseau ME,Schaefer EJ,Wolfe ML,Bloedon LT,Digenio AG,Clark RW,et al.Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol.N Engl J Med,2004,350 (15):1 505-515
5Assmann G,Gotto AM Jr.HDL cholesterol and protective factors in atherosclerosis.Circulation,2004,109 (23 Suppl 1):Ⅲ8-14
6Karlsson H,Leanderson P,Tagesson C,Lindahl M.Lipoproteomics II:Mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry.Proteomics,2005,5 (5):1 431-445
7Khovidhunkit W,Duchateau PN,Medzihradszky KF,Moser AH,Naya-Vigne J,Shigenaga JK,et al.Apolipoproteins A-IV and A-V are acute-phase proteins in mouse HDL.Atherosclerosis,2004,176 (1):37-44
8Asztalos BF,Cupples LA,Serkalem Demissie,Horvath KV,Cox CE,Batista MC,et al.High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the framingham offspring study.Arterioscler Thromb Vasc Biol,2004,24 (11):2 181-187
9Yang Y,Yan B,Fu M,Xu Y,Tian Y.Relationship between plasma lipid concentrations and HDL subclasses.Clin Chim Acta,2005,354(1):49-58
10Wang X,Paigen B.Genetics of variation in HDL cholesterol in humans and mice.Circ Res,2005,96 (1):27-42
2Aslold BO,Vatten LJ,Nilsen Tl,et al.The association between TSH with- in the refence range and serum lipid concentrations in a population- based study.The HUNT Study. [J].Eur J Endocrinol,2007,156(6):181- 186.
3Sasaki S,Kawai K.Thyroid hoemones and lipid metabolism[J].Nippon Rinsho,2006,64(12) : 2323-2329.
4Dutas LH.Thyroid disease and lipids [J].Thyroid,2002,12(4):287-293.
5Waterhouse DF,Mclaughlin A M,Walsh CD,et al.An examination of the relationship between normal range thyrotropin and cardiovascular risk parameters:a study in healthy women[J].Thyroid,2007,17(3):243-248.
6Duntas LH,Wartofsky L.Cardiovascular risk and subclinical hypothy- roidism :focus on lipids and new emerging risk fackors.What is the evi- dence?[J].Thyroid,2007,17(11): 1075-1084.
